Burn Wounds

3

Review clinical trials related to Burn Wounds. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

HUMSCs Combined With Col I to Third-Degree Burn Wound

To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.

Participants needed: 108
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Xinxiang Medical CollegeUpdated: May 4, 2026Locations: 1
Eligibility criteria

Aged 18-65 years, gender unrestricted [+4]

Pregnant or lactating females [+7]

Status: Recruiting

The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing

The process of dressing burn injuries has been shown to cause both physical and psychological difficulties. In children, this process is particularly associated with intense pain and anxiety. Consequently, in addition to pharmacological interventions, non-pharmacological methods such as distraction are employed. In recent years, the utilization of holograms as a method of alleviating pain has emerged as a novel approach. The employment of these visual illusions has been demonstrated to effectively distract children, thereby providing a means of reducing discomfort. The objective of this thesis is to evaluate the effects of hologram application on pain, anxiety, fear, and vital signs during burn dressing in children.

Participants needed: 70
Trial details
Age: 3-12Biological sex: AllType: InterventionalSponsor: Ataturk UniversityUpdated: Apr 13, 2026Locations: 2
Eligibility criteria

The subject has indicated their willingness to participate in the study. Physica... [+4]

The subject is unwilling or unable to provide informed consent or assent (if app... [+5]

Status: Not yet recruiting

Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds

Chronic wounds constitute a significant global health burden, affecting millions of individuals and contributing to increased morbidity, diminished quality of life, and rising healthcare costs. These wounds are characterized by delayed healing and are often associated with complex etiologies and prolonged treatment courses. This study aims to evaluate the clinical efficacy and cost-effectiveness of Carbonlife amniotic tissue products (ATPs) compared to standard wound care in the management of chronic wounds. A prospective, controlled clinical trial will be conducted across diverse care settings and patient populations with varying wound etiologies. Participants will be stratified by wound type and treatment environment to enable subgroup analyses. The primary endpoint will assess wound healing outcomes, while secondary endpoints will include quality-of-life measures and healthcare resource utilization. The study is designed to generate high-quality evidence regarding the therapeutic value of ATPs in chronic wound management. Stratified analyses will provide insights into the differential effectiveness of ATPs across clinical contexts. Findings are anticipated to have implications for clinical practice guidelines and healthcare policy, with the goal of improving patient outcomes and optimizing resource allocation in wound care.

Participants needed: 600
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Bardia AnvarUpdated: Nov 6, 2025
Eligibility criteria

Facilities and centers with the capacity to follow strict treatment and care gui... [+4]

Presence of active osteomyelitis [+5]